Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Redrawing the Map to Novel DILI Biomarkers in Circulation: Where Are We, Where Should We Go, and How Can We Get There?

Livers(2021)10.3390/livers1040022Source: DataRank Database

Redrawing the Map to Novel DILI Biomarkers in Circulation: Where Are We, Where Should We Go, and How Can We Get There? is a research paper published in Livers (2021). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.19)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Mitchell R. McGill ORCID,Joel H. Vazquez ORCID

Live enrichment

PubMed:34966905 PMC:PMC8713950 OpenAlex:https://openalex.org/W3215589231

American Association for the Study of Liver Diseases

Grant: 2018 Pinnacle Award

National Institutes of Health

Grant: T32 GM106999

National Institutes of Health

Grant: 5T32GM106999-09

Systems Pharmacology and Toxicology Training Program

FWCI

2.19

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://www.mdpi.com/2673-4389/1/4/22/pdf?version=1638346778

publisherhttps://www.mdpi.com/2673-4389/1/4/22/pdf?version=1638346778

publisherhttps://www.mdpi.com/2673-4389/1/4/22/pdf

journalhttps://doi.org/10.3390/livers1040022

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34966905

Fields of Study

Drug-Induced Hepatotoxicity and ProtectionMetabolomics and Mass Spectrometry StudiesLiver Disease Diagnosis and Treatment0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

BiomarkerBiomarker discoveryMedicineLiver injuryDrug discoveryDrug developmentBioinformaticsComputational biologyComputer scienceDrugProteomicsInternal medicineBiologyPharmacologyGeneRegulationDiagnosisHepatotoxicityPrognosisAcute liver failureDrug-induced Liver InjuryMedicine (General)R5-920

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being